1,157
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Matrix Polymeric Excipients: Comparing a Novel Interpolyelectrolyte Complex with Hydroxypropylmethylcellulose

, , &
Pages 87-96 | Received 24 Apr 2007, Accepted 20 Aug 2007, Published online: 10 Oct 2008

REFERENCES

  • Berger J., Reist M., Mayer J. M., Felt O., Peppas N. A., Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004; 57: 19–34
  • Chen S.-C., Wu Y.-C., Mi F.-L., Lin Y.-H., Yu L.-C., Sung H.-W. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J. Control. Rel. 2004; 96: 285–300
  • Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Deliv. Rev. 1993; 11: 37–57
  • Dumitriu S., Chornet E. Inclusion and release of proteins from polysaccharide-base polyion complexes. Adv. Drug Deliv. Rev. 1998; 31: 223–246
  • Ford J. L., Rubinstein M. H., McCaul F., Hogan J. E., Edgar P. J. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxylpropyl methylcellulose matrix tablets. Int. J. Pharm. 1987; 40: 223–234
  • Garcia A. M., Ghaly E. S. Preliminary spherical agglomerates of water soluble drug using natural polymer and cross-linking technique. J. Control. Rel. 1996; 40: 179–186
  • Hosmani A. H. Carbopol and its pharmaceutical significance: a review. Pharmainfo 2006; 1–4
  • Jamzad S., Fassihi R. Development of a controlled release low dose class II drug-Glipizide. Int. J. Pharm. 2006; 312: 24–32
  • Lorenzo-Lamosa M. L., Remuñán-López C., Vila-Jato J. L., Alonso M. J. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Rel. 1998; 52: 109–118
  • Lu Z., Chen W., Hamman J. H. Chitosan-polycarbophil complexes in swellable matrix systems for controlled drug release. Curr. Drug Deliv. 2007; 4(4)257–263
  • Margulis E. B., Moustafine R. I. Swellability testing of chitosan/Eudragit® L100–55 interpolyelectrolyte complexes for colonic drug delivery. J. Control. Rel. 2006; 116: e36–e37
  • Moore J. W., Flanner H. H. Mathematical comparison of dissolution profiles. Pharm. Tech. 1996; 20: 64–74
  • Moustafine R. I., Kabanova T. V., Kemenova V. A., Van den Mooter G. Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J. Control. Rel. 2005; 103: 191–198
  • Nam K., Watanabe J., Ishihara K. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition. Eur. J. Pharm. Sci. 2004; 23: 261–270
  • Paul W., Sharma C. P. Chitosan, a drug carrier for the 21st century: a review. S.T.P. Pharma Sci. 2000; 10: 5–22
  • Peppas N. A. Analysis of fickian and non-fickian drug release from polymers. Pharm. Acta Helv. 1985; 60: 110–111
  • Peppas N. A., Khare A. R. Preparation, structure and diffusion behaviour of hydrogels in controlled release. Adv. Drug Deliv. Rev. 1993; 11: 1–35
  • Pillai O., Panchagnula R. Polymers in drug delivery. Curr. Opin. Chem. Biol. 2001; 5: 447–451
  • Pillay V., Fassihi R. A new method for dissolution studies of lipid filled capsules employing nifedipine as a model drug. Pharm. Res. 1999; 16: 333–338
  • Rao K. V. R., Padmalatha Devi K., Buri P. Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J. Control. Rel. 1990; 12: 133–141
  • Reppas C., Nicolaides E. Analysis of drug dissolution data. Oral Drug Absorption Prediction and Assessment, J. B. Dressman, H. Lennernäs. Marcel Dekker, New York 2000; 229–254
  • Reynolds T. D., Gehrke S. H., Hussain A. S., Shenouda L. S. Polymer erosion and drug release characterization of hydroxylpropyl methylcellulose matrices. J. Pharm. Sci. 1998; 87: 1115–1123
  • Ritger P. L., Peppas N. A. A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J. Control. Rel. 1987; 5: 37–42
  • Sankalia M. G., Mashru R. C., Sankalia J. M., Sutariya V. B. Reversed chitosan–alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur. J. Pharm. Biopharm. 2007; 65: 215–232
  • Siepmann J., Kranz H., Bodmeier R., Peppas N. A. HPMC matrices for controlled drug delivery: a new model combining diffusion, swelling and dissolution mechanisms and predicting the release kinetics. Pharm. Res. 1999; 16: 1748–1756
  • Siepmann J., Peppas N. A. Modelling of drug release from delivery systems based on hydroxylpropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001; 48: 139–157
  • Sopprinath K. S., Aminabhavi T. M. Water transport and drug release study from cross-linked polyacrylamide grafted guar gum hydrogel microspheres for the controlled release application. Eur. J. Pharm. Biopharm. 2002; 53: 87–98
  • Sousa J. J., Sousa A., Moura M. J., Podczeck F., Nowton J. M. The influence of core materials and film coating on the drug release from coated pellets. Int. J. Pharm. 2002; 233: 111–122
  • Tahara K., Yamamoto K., Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxylpropylmethylcellulose 2910. J. Control. Rel. 1995; 35: 59–66

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.